![](https://static.isu.pub/fe/default-story-images/news.jpg?width=720&quality=85%2C50)
1 minute read
Report Description Report Description and Highlights
Global Extracorporeal Membrane Oxygenation Machine Market Research Report 20222027: According to the latest report by IMARC Group, titled " ExtracorporealMembraneOxygenationMachineMarket:GlobalIndustryTrends,Share,Size,Grow th,OpportunityandForecast2022-2027
," the global extracorporeal membrane oxygenation machine market is expected to grow at a CAGR of 5.3% during 2022-2027.
Advertisement
Extracorporeal membrane oxygenation (ECMO) machine offers prolonged cardiac and respiratory support to patients during transplant surgeries. This miniaturized heart-lung equipment is used for draining the blood for oxygenating red blood cells (RBCs), removing carbon dioxide from the patient’s body and then pumping to circulate blood via an artificial lung back into the bloodstream of the individual. Apart from this, these devices can also be utilized in late-stage treatments or postcardiopulmonary bypass with heart or lung failure. We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.
Request for a PDF sample of this report: https://www.imarcgroup.com/extracorporeal-membrane-oxygenation-machine-market/requestsa mple
Global Extracorporeal Membrane Oxygenation Machine Market Trends:
The global market is majorly driven by the rising prevalence of respiratory and cardiovascular disorders. This is also supported by the growing geriatric population across the globe that is more prone to develop such medical conditions. Since ECMO is widely used for individuals suffering from respiratory or cardiac failure as a result of trauma, congenital disabilities or severe infections, this is providing a boost to the market growth. The market is further driven by the continual integration of ECMO devices with advanced technologies.
For instance, the advent of polymethyl pentene (PMP) fiber-based artificial membranes with enhanced biocompatibility and low resistance is gaining widespread prominence across healthcare settings. Some of the other factors contributing to the market growth include the launch of portable product variants, increasing healthcare expenditure capacity, and extensive research and development (R&D) activities conducted by key players to introduce ECMO devices with convenient oxygenation of the blood.
View Report TOC, Figures and Tables: https://www.imarcgroup.com/extracorporeal-membrane-oxygenation-machine-market